$ASNS
ACTELIS NETWORKS INC Stock $asns

$asns Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000121390024026069 Filed on March 26, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$726.0K	$1.017M	$5.606M
YoY Change	-60.71%	-59.87%	-36.52%
Cost Of Revenue	$506.0K	$663.0K	$3.706M
YoY Change	-56.38%	-54.68%	-21.5%
Gross Profit	$220.0K	$354.0K	$1.900M
YoY Change	-68.02%	-66.95%	-53.77%
Gross Profit Margin	30.3%	34.81%	33.89%
Selling, General & Admin	$1.444M	$1.424M	$6.561M
YoY Change	-19.51%	-39.61%	-11.87%
% of Gross Profit	656.36%	402.26%	345.32%
Research & Development	$647.0K	$585.0K	$2.702M
YoY Change	-14.53%	-18.41%	-2.31%
% of Gross Profit	294.09%	165.25%	142.21%
Depreciation & Amortization	$4.000K	$7.000K	$27.00K
YoY Change	-42.86%	-216.67%	17.39%
% of Gross Profit	1.82%	1.98%	1.42%
Operating Expenses	$2.091M	$2.009M	$9.263M
YoY Change	-18.03%	-34.67%	-9.28%
Operating Profit	-$1.871M	-$1.655M	-$7.363M
YoY Change	0.43%	-17.42%	20.69%
Interest Expense	-$61.00K	-$276.0K	-$453.0K
YoY Change	-133.89%	-42.26%	-154.58%
% of Operating Profit
Other Income/Expense, Net	$92.00K		$1.530M
YoY Change	-37.84%		-137.77%
Pretax Income	-$1.986M	-$1.931M	-$6.286M
YoY Change	4.8%	-22.2%	-42.76%
Income Tax
% Of Pretax Income
Net Earnings	-$1.986M	-$1.931M	-$6.286M
YoY Change	4.8%	-22.2%	-42.76%
Net Earnings / Revenue	-273.55%	-189.87%	-112.13%
Basic Earnings Per Share	-$0.50		-$2.61
Diluted Earnings Per Share	-$0.50	-$0.67	-$2.61
COMMON SHARES
Basic Shares Outstanding	3.020M shares	2.716M shares	2.413M shares
Diluted Shares Outstanding	3.979M shares		2.413M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.408M	$817.0K	$817.0K
YoY Change	-12.98%	-85.32%	-85.32%
Cash & Equivalents	$1.211M	$620.0K	$620.0K
Short-Term Investments	$197.0K	$197.0K	$197.0K
Other Short-Term Assets	$1.641M	$1.905M	$1.847M
YoY Change	37.55%	68.73%	75.24%
Inventory	$2.608M	$2.526M	$2.526M
Prepaid Expenses		$198.0K
Receivables	$533.0K	$664.0K	$722.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$6.190M	$5.912M	$5.912M
YoY Change	-5.61%	-45.8%	-45.8%
LONG-TERM ASSETS
Property, Plant & Equipment	$58.00K	$61.00K	$61.00K
YoY Change	-23.68%	-23.75%	-23.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.268M	$5.250M	$5.250M
YoY Change	-20.48%	37.0%	37.0%
Total Long-Term Assets	$4.326M	$5.311M	$5.311M
YoY Change	-20.52%	35.76%	35.76%
TOTAL ASSETS
Total Short-Term Assets	$6.190M	$5.912M	$5.912M
Total Long-Term Assets	$4.326M	$5.311M	$5.311M
Total Assets	$10.52M	$11.22M	$11.22M
YoY Change	-12.37%	-24.27%	-24.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.258M	$1.769M	$1.769M
YoY Change	61.29%	-0.67%	-0.67%
Accrued Expenses	$2.667M	$2.682M	$2.682M
YoY Change	11.64%	125.38%	25.44%
Deferred Revenue		$389.0K
YoY Change
Short-Term Debt	$574.0K	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.088M	$1.335M	$1.335M
YoY Change	-9.78%	141.41%	141.41%
Total Short-Term Liabilities	$8.890M	$6.912M	$6.912M
YoY Change	39.52%	11.45%	11.45%
LONG-TERM LIABILITIES
Long-Term Debt	$2.521M	$3.154M	$3.154M
YoY Change	-32.09%	-31.81%	-31.81%
Other Long-Term Liabilities	$23.00K	$769.0K	$769.0K
YoY Change	-30.3%	5.78%	5.78%
Total Long-Term Liabilities	$3.135M	$3.923M	$3.923M
YoY Change	-25.61%	-26.7%	-26.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.890M	$6.912M	$6.912M
Total Long-Term Liabilities	$3.135M	$3.923M	$3.923M
Total Liabilities	$12.03M	$10.84M	$10.84M
YoY Change	13.59%	-6.22%	-6.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$41.67M	-$39.69M
YoY Change	18.07%	18.82%
Common Stock	$1.000K	$39.92M
YoY Change	0.0%	3991600.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.668M	$388.0K	$388.0K
YoY Change
Total Liabilities & Shareholders Equity	$10.52M	$11.22M	$11.22M
YoY Change	-12.37%	-24.27%	-24.27%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$1.986M	-$1.931M	-$6.286M
YoY Change	4.8%	-22.2%	-42.76%
Depreciation, Depletion And Amortization	$4.000K	$7.000K	$27.00K
YoY Change	-42.86%	-216.67%	17.39%
Cash From Operating Activities	-$203.0K	-$1.387M	-$6.577M
YoY Change	-88.09%	-30.37%	-15.33%
INVESTING ACTIVITIES
Capital Expenditures	$1.000K	-$1.000K	$9.000K
YoY Change	-66.67%	-97.06%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$2.390M	$3.830M
YoY Change	-100.0%	-160.26%	-194.94%
Cash From Investing Activities	-$1.000K	$2.391M	$3.821M
YoY Change	-99.7%	-160.81%	-194.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$4.950M
YoY Change
Debt Paid & Issued, Net	$193.0K		$769.0K
YoY Change	0.52%		-38.03%
Cash From Financing Activities	-$164.0K	1.171M	3.761M
YoY Change	-32.23%	-257.82%	-75.4%
NET CHANGE
Cash From Operating Activities	-$203.0K	-1.387M	-6.577M
Cash From Investing Activities	-$1.000K	2.391M	3.821M
Cash From Financing Activities	-$164.0K	1.171M	3.761M
Net Change In Cash	-$370.0K	2.175M	1.005M
YoY Change	-83.78%	-132.63%	-71.15%
FREE CASH FLOW
Cash From Operating Activities	-$203.0K	-$1.387M	-$6.577M
Capital Expenditures	$1.000K	-$1.000K	$9.000K
Free Cash Flow	-$204.0K	-$1.386M	-$6.586M
YoY Change	-88.06%	-29.21%	-15.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	229000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.61
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41375
CY2023	dei	Entity Registrant Name EntityRegistrantName	Actelis Networks, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-2160309
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	4039 Clipper Court
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Fremont
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94538
CY2023	dei	City Area Code CityAreaCode	(510)
CY2023	dei	Local Phone Number LocalPhoneNumber	545-1045
CY2023	dei	Security12b Title Security12bTitle	Common stock, par value $0.0001 per share
CY2023	dei	Trading Symbol TradingSymbol	ASNS
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	5472624	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3020268	shares
CY2023	dei	Auditor Firm AuditorFirmId	1309
CY2023	dei	Auditor Name AuditorName	Kesselman & Kesselman
CY2023	dei	Auditor Location AuditorLocation	Tel Aviv, Israel
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	620000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3943000	usd
CY2023Q4	us-gaap	Restricted Cash Equivalents Current RestrictedCashEquivalentsCurrent	1565000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	197000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	1622000	usd
CY2022Q4	asns	Restricted Bank Deposits Current RestrictedBankDepositsCurrent	451000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	168000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	125000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	664000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	3034000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2526000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1179000	usd
CY2023Q4	asns	Allowance For Doubtful Debts Prepaid Expenses AllowanceForDoubtfulDebtsPrepaidExpenses	144000	usd
CY2022Q4	asns	Allowance For Doubtful Debts Prepaid Expenses AllowanceForDoubtfulDebtsPrepaidExpenses	0	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	340000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	678000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	5912000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	10907000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	61000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	80000	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	592000	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	492000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3330000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	336000	usd
CY2023Q4	asns	Restricted Bank Deposits Noncurrent RestrictedBankDepositsNoncurrent	94000	usd
CY2022Q4	asns	Restricted Bank Deposits Noncurrent RestrictedBankDepositsNoncurrent	2027000	usd
CY2023Q4	asns	Severance Pay Fund Noncurrent SeverancePayFundNoncurrent	238000	usd
CY2022Q4	asns	Severance Pay Fund Noncurrent SeverancePayFundNoncurrent	239000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	918000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	726000	usd
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	78000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	12000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	5311000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3912000	usd
CY2023Q4	us-gaap	Assets Assets	11223000	usd
CY2022Q4	us-gaap	Assets Assets	14819000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1335000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	553000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1769000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1781000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	389000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	484000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	737000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	793000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1062000	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	900000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	498000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	445000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1122000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1246000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6912000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6202000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3154000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4625000	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	71000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	405000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	237000	usd
CY2023Q4	asns	Accrued Severance Noncurrent AccruedSeveranceNoncurrent	270000	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	164000	usd
CY2022Q4	asns	Accrued Severance Noncurrent AccruedSeveranceNoncurrent	278000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	23000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	48000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3923000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5352000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	10835000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	11554000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	asns	Warrants To Placement Agent WarrantsToPlacementAgent	159000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3007745	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3007745	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1737986	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1737986	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	39916000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	36666000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39688000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33402000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3265000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11223000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14819000	usd
CY2023	us-gaap	Revenues Revenues	5606000	usd
CY2022	us-gaap	Revenues Revenues	8831000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	3706000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	4721000	usd
CY2023	us-gaap	Gross Profit GrossProfit	1900000	usd
CY2022	us-gaap	Gross Profit GrossProfit	4110000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2702000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2766000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3030000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3282000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3531000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4163000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	9263000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	10211000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-7363000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-6101000	usd
CY2023	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	766000	usd
CY2022	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	830000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1843000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4051000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6286000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-10982000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-9.45
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2412717	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1162124	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-19596000	usd
CY2022	asns	Short Term Deposit Net ShortTermDepositNet	-1622000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	220000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5585000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14675000	usd
CY2022	asns	Stock Issue During Period Value Conversion Of Convertible Loan To Common Stock Upon Initial Public Offering StockIssueDuringPeriodValueConversionOfConvertibleLoanToCommonStockUponInitialPublicOffering	6553000	usd
CY2022	asns	Stock Issue During Period Value Conversion Of Convertible Note To Common Stock Upon Initial Public Offering StockIssueDuringPeriodValueConversionOfConvertibleNoteToCommonStockUponInitialPublicOffering	3600000	usd
CY2022	asns	Stock Issue During Period Value Conversion Of Warrants To Common Stock Upon Initial Public Offering StockIssueDuringPeriodValueConversionOfWarrantsToCommonStockUponInitialPublicOffering	3190000	usd
CY2022	asns	Stock Issued During Period Values Repurchase Of Common Stock StockIssuedDuringPeriodValuesRepurchaseOfCommonStock	-15000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-10982000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3265000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	377000	usd
CY2023	asns	Stock Issued During Period Values Repurchase Of Common Stock StockIssuedDuringPeriodValuesRepurchaseOfCommonStock	50000	usd
CY2023	asns	Stock Issued During Period Value Issuance Of Common Stock And Prefunded Warrants Upon Private Placement Net Of Underwriting StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsUponPrivatePlacementNetOfUnderwriting	2609000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	314000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6286000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	229000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6286000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-10982000	usd
CY2023	us-gaap	Depreciation Depreciation	27000	usd
CY2022	us-gaap	Depreciation Depreciation	23000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1658000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1049000	usd
CY2023	asns	Warrant Issuance Costs WarrantIssuanceCosts	223000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	239000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	147000	usd
CY2023	asns	Exchange Rate Difference ExchangeRateDifference	460000	usd
CY2022	asns	Exchange Rate Difference ExchangeRateDifference	627000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	377000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	220000	usd
CY2022	asns	Changes In Fair Value Related To Convertible Loan ChangesInFairValueRelatedToConvertibleLoan	1648000	usd
CY2022	asns	Changes In Fair Value Related To Convertible Note ChangesInFairValueRelatedToConvertibleNote	1753000	usd
CY2023	us-gaap	Interest Expense InterestExpense	295000	usd
CY2022	us-gaap	Interest Expense InterestExpense	830000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2370000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	887000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-19000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	44000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1585000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	429000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-357000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	280000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	100000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	492000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-25000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-139000	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-188000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-25000	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-172000	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	508000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-10000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-41000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6577000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7768000	usd
CY2023	asns	Short Term Deposit Net ShortTermDepositNet	1418000	usd
CY2023	asns	Payments For Proceeds From Long Term Deposit PaymentsForProceedsFromLongTermDeposit	56000	usd
CY2022	asns	Payments For Proceeds From Long Term Deposit PaymentsForProceedsFromLongTermDeposit	-66000	usd
CY2023	asns	Long Term Restricted Bank Deposits LongTermRestrictedBankDeposits	4827000	usd
CY2023	asns	Deposit Of Restricted Longterm Bank Deposits DepositOfRestrictedLongtermBankDeposits	-2810000	usd
CY2022	asns	Deposit Of Restricted Longterm Bank Deposits DepositOfRestrictedLongtermBankDeposits	-27000	usd
CY2023	asns	Restricted Short Term Bank Deposit RestrictedShortTermBankDeposit	-451000	usd
CY2022	asns	Restricted Short Term Bank Deposit RestrictedShortTermBankDeposit	2451000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3821000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4034000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5000	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	18697000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5000000	usd
CY2023	asns	Underwriting Discounts And Commissions And Other Offering Costs UnderwritingDiscountsAndCommissionsAndOtherOfferingCosts	420000	usd
CY2022	asns	Underwriting Discounts And Commissions And Other Offering Costs UnderwritingDiscountsAndCommissionsAndOtherOfferingCosts	2175000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50000	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	769000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1241000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3761000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15286000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	231000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-72000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1236000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3484000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4279000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	795000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5515000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4279000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	620000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3943000	usd
CY2023Q4	us-gaap	Restricted Cash Equivalents Current RestrictedCashEquivalentsCurrent	1565000	usd
CY2023Q4	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	3330000	usd
CY2022Q4	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	336000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5515000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4279000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	431000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	818000	usd
CY2023	asns	Right Of Use Assets Obtained In Exchange For New Operating Lease Liabilities RightOfUseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities	702000	usd
CY2022	asns	Right Of Use Assets Obtained In Exchange For New Operating Lease Liabilities RightOfUseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities	237000	usd
CY2022	asns	Conversion Of Convertible Loan To Common Stock Upon Initial Public Offering ConversionOfConvertibleLoanToCommonStockUponInitialPublicOffering	6553000	usd
CY2022	asns	Conversion Of Convertible Note To Common Stock Upon Initial Public Offering ConversionOfConvertibleNoteToCommonStockUponInitialPublicOffering	3600000	usd
CY2022	asns	Conversion Of Warrant To Common Stock Upon Initial Public Offering ConversionOfWarrantToCommonStockUponInitialPublicOffering	3190000	usd
CY2022	asns	Conversion Of Convertible Redeemable Preferred Stock To Common Stock Upon Initial Public Offering ConversionOfConvertibleRedeemablePreferredStockToCommonStockUponInitialPublicOffering	5585000	usd
CY2022	asns	Repurchases Of Common Stock RepurchasesOfCommonStock	15000	usd
CY2023	asns	Issuance Costs Of Common Stock Prefunded Warrants And Warrants IssuanceCostsOfCommonStockPrefundedWarrantsAndWarrants	159000	usd
CY2023	asns	Reclassification Of Warrants From Liability To Equity Upon Amendment To Private Placement Agreem ReclassificationOfWarrantsFromLiabilityToEquityUponAmendmentToPrivatePlacementAgreem	314000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6286000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-10982000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7768000	usd
CY2023Q4	us-gaap	Cash Cash	2382000	usd
CY2023Q4	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	3424000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of estimates in preparation of financial statements </b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company evaluates on an ongoing basis its assumptions, including those related to Fair value of financial instruments, inventory write-offs, as well as in estimates used in applying the revenue recognition policy. The Company’s management believes that the estimates, judgment, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of liabilities at the dates of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	168000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	125000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	43000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	64000	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1000000	usd
CY2023	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	0.0001
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	8000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	8000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>q.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentrations of credit risk</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, trade receivables and Restricted bank deposits. Cash and cash equivalents and restricted cash are placed with banks and financial institutions in the United States and Israel.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Management believes that the financial institutions that hold the Company’s investments are financially sound and, accordingly, present minimal credit risk with respect to those investments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company’s trade receivables are derived primarily from telecommunication operators, the Company’s reseller customers and enterprises located mainly in the United States, Europe, and Asia.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Credit risk with respect to trade receivables exists to the full extent of the amounts presented in the consolidated financial statements. Management makes judgments as to its ability to collect outstanding accounts receivable and provides allowances for the applicable portion of accounts receivable when collection becomes doubtful.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Management provides allowances based upon a specific review of all significant outstanding invoices, analysis of its historical collection experience, and current economic trends. If the historical data used to calculate the allowance for doubtful accounts does not reflect the Company’s future ability to collect outstanding accounts receivable, additional provisions for doubtful accounts may be needed, and the future results of operations could be materially affected.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company has customers balances representing 10% or more of Trade receivables as follows:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 1in"> </td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer A- 30% and 5% of the Company Trade receivables balance as of December 31, 2023 and December 31, 2022 respectively.</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 1in"> </td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer B- 11% and 29% of the Company Trade receivables balance as of December 31, 2023 and December 31, 2022 respectively.</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 1in"> </td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer C- 11% and 1% of the Company Trade receivables balance as of December 31, 2023 and December 31, 2022 respectively.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">See note 17 for details regarding the revenues from these customers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company does not see any credit risk regarding this balance, as most of the remaining balance was paid off after the balance sheet date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p>
CY2023Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P2Y
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	47000	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	96000	usd
CY2023	asns	Revenues Percentage RevenuesPercentage	0.03	pure
CY2023	us-gaap	Royalty Expense RoyaltyExpense	334000	usd
CY2022	us-gaap	Royalty Expense RoyaltyExpense	257000	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.50	pure
CY2023	us-gaap	Other Labor Related Expenses OtherLaborRelatedExpenses	175000	usd
CY2022	us-gaap	Other Labor Related Expenses OtherLaborRelatedExpenses	182000	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	5000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-4000	usd
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	8000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	9000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2023	asns	Restricted Stock Units Term RestrictedStockUnitsTerm	P3Y
CY2023	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.40	pure
CY2023	us-gaap	Workers Compensation Discount Percent WorkersCompensationDiscountPercent	0.65	pure
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	757000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	593000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1769000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	586000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2526000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1179000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	239000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	147000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	198000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	473000	usd
CY2023Q4	asns	Governmental Authorities GovernmentalAuthorities	84000	usd
CY2022Q4	asns	Governmental Authorities GovernmentalAuthorities	130000	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	58000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	75000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	340000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	678000	usd
CY2023Q4	asns	Allowance For Doubtful Debts Prepaid Expenses AllowanceForDoubtfulDebtsPrepaidExpenses	144000	usd
CY2022Q4	asns	Allowance For Doubtful Debts Prepaid Expenses AllowanceForDoubtfulDebtsPrepaidExpenses	0	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9747000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9739000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9686000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9659000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	61000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	80000	usd
CY2023	us-gaap	Depreciation Depreciation	27000	usd
CY2022	us-gaap	Depreciation Depreciation	23000	usd
CY2023	us-gaap	Leveraged Leases Income Statement Investment Tax Credit Recognized On Leveraged Leases LeveragedLeasesIncomeStatementInvestmentTaxCreditRecognizedOnLeveragedLeases	119000	usd
CY2022	us-gaap	Leveraged Leases Income Statement Investment Tax Credit Recognized On Leveraged Leases LeveragedLeasesIncomeStatementInvestmentTaxCreditRecognizedOnLeveragedLeases	168000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	918000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	726000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	498000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	445000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	405000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	237000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	903000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	682000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	478000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	747000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.102	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0349	pure
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	459000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	723000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	19000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	24000	usd
CY2023	us-gaap	Lease Cost LeaseCost	478000	usd
CY2022	us-gaap	Lease Cost LeaseCost	747000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	548000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	433000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	6000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	987000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	84000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	903000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	955000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1190000	usd
CY2023Q4	asns	Accrued Standard Warranty AccruedStandardWarranty	24000	usd
CY2022Q4	asns	Accrued Standard Warranty AccruedStandardWarranty	48000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	143000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1122000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1246000	usd
CY2020Q3	us-gaap	Amount Of Regulatory Assistance Received1 AmountOfRegulatoryAssistanceReceived1	150000	usd
CY2023Q4	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	148000	usd
CY2020Q4	us-gaap	Loans Payable LoansPayable	20000000	ils
CY2020Q4	us-gaap	Loans Payable LoansPayable	6000000	usd
CY2020Q4	us-gaap	Financing Receivable Loan In Process FinancingReceivableLoanInProcess	3000000	usd
CY2021Q1	asns	Additional Loan Value AdditionalLoanValue	2000000	usd
CY2021Q4	us-gaap	Investment Company Increase From Payment By Affiliate And Gain Loss From Investment In Violation InvestmentCompanyIncreaseFromPaymentByAffiliateAndGainLossFromInvestmentInViolation	1000000	usd
CY2023	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1	1800000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	4339000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	1333000	usd
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	60000	usd
CY2022Q4	us-gaap	Carrying Value Of Securities Sold Under Repurchase Agreements And Deposits Received For Securities Loaned CarryingValueOfSecuritiesSoldUnderRepurchaseAgreementsAndDepositsReceivedForSecuritiesLoaned	2000000	usd
CY2023Q4	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	2000000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	9000	usd
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5567000	ils
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1535000	usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1080000	ils
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	298000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	9000	usd
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3684000	ils
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1016000	usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	704000	ils
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	194000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	9000	usd
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	3684000	ils
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1016000	usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	704000	ils
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	194000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	9000	usd
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	3684000	ils
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1016000	usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	704000	ils
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	194000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	225000	usd
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	305000	ils
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	84000	usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	59000	ils
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	16000	usd
CY2023Q4	asns	Long Term Debt Less Accumulated Interest LongTermDebtLessAccumulatedInterest	-113000	usd
CY2021Q1	asns	Long Term Debt Less Accumulated Interest LongTermDebtLessAccumulatedInterest	3635000	ils
CY2021Q1	asns	Long Term Debt Less Accumulated Interest LongTermDebtLessAccumulatedInterest	1003000	usd
CY2021Q4	asns	Long Term Debt Less Accumulated Interest LongTermDebtLessAccumulatedInterest	804000	ils
CY2021Q4	asns	Long Term Debt Less Accumulated Interest LongTermDebtLessAccumulatedInterest	221000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	148000	usd
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	13289000	ils
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	3664000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2447000	ils
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	675000	usd
CY2023Q4	asns	Exchange Rate ExchangeRate	1
CY2023Q4	asns	Exchange Rate ExchangeRate	3.627
	asns	Convertible Note Offering Amount ConvertibleNoteOfferingAmount	3000000	usd
	asns	Convertible Note Offering Percentage ConvertibleNoteOfferingPercentage	0.06	pure
CY2022Q1	asns	Convertible Note Offered ConvertibleNoteOffered	3000000	usd
CY2023	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.40	pure
CY2023Q4	us-gaap	Debt Instrument Convertible Liquidation Preference Value DebtInstrumentConvertibleLiquidationPreferenceValue	50000	usd
CY2023	asns	Conversion Notes Payable ConversionNotesPayable	1.10	pure
CY2022	asns	Additions To Notes AdditionsToNotes	1847000	usd
CY2022	asns	Changes In Fair Value Related To Convertible Note ChangesInFairValueRelatedToConvertibleNote	1753000	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	3600000	usd
CY2022	us-gaap	Other Expenses OtherExpenses	1753000	usd
CY2021Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	4905000	usd
CY2022	asns	Changes In Fair Value Related To Convertible Loan ChangesInFairValueRelatedToConvertibleLoan	1648000	usd
CY2022	asns	Conversion Of Stock Amount Issued ConversionOfStockAmountIssued	6553000	usd
CY2022	asns	Changes In Fair Value Related To Convertible Loan ChangesInFairValueRelatedToConvertibleLoan	1648000	usd
CY2023	us-gaap	Credit Derivative Liquidation Proceeds Percentage CreditDerivativeLiquidationProceedsPercentage	1	pure
CY2023Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	14300000	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	15736000	usd
CY2023Q4	us-gaap	Recorded Unconditional Purchase Obligation Amount Of Maturities And Sinking Fund Requirements RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements	10275000	usd
CY2023	us-gaap	Payments For Royalties PaymentsForRoyalties	1062000	usd
CY2022	us-gaap	Payments For Royalties PaymentsForRoyalties	900000	usd
CY2023	asns	Aggregate Gross Proceeds AggregateGrossProceeds	5000000	usd
CY2023	asns	Valuation Amount ValuationAmount	15000000	usd
CY2023Q4	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	8	pure
CY2022Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	8000	usd
CY2021Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	2149000	usd
CY2023	us-gaap	Additions To Other Assets Amount AdditionsToOtherAssetsAmount	1972000	usd
CY2023	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	-1726000	usd
CY2022	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	1049000	usd
CY2023	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	68000	usd
CY2022Q4	asns	Conversion To The Companys Common Stock ConversionToTheCompanysCommonStock	-3190000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	314000	usd
CY2023Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	8000	usd
CY2022Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	8000	usd
CY2023	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-1726	usd
CY2022	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	1049000	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3007745	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1737986	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	29487	shares
CY2022Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	145000	usd
CY2023Q2	us-gaap	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	3500000	usd
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	190000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	asns	Pre Funded Warrants To Purchase Common Shares PreFundedWarrantsToPurchaseCommonShares	754670	shares
CY2023Q2	asns	Prefunded Warrants PrefundedWarrants	754670	shares
CY2023Q2	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	0.0001
CY2023	us-gaap	Other General Expense OtherGeneralExpense	68000	usd
CY2023Q3	asns	Exercise Of Prefunded Warrant ExerciseOfPrefundedWarrant	754670	shares
CY2023Q3	asns	Exercise Of Prefunded Warrant ExerciseOfPrefundedWarrant	754670	shares
CY2023Q3	asns	Exercise Price Of Prefunded Warrant ExercisePriceOfPrefundedWarrant	0.0755
CY2023Q3	asns	Exercise Price Of Prefunded Warrant ExercisePriceOfPrefundedWarrant	0.0755
CY2023Q2	asns	Payments To Underwriter PaymentsToUnderwriter	291000	usd
CY2023Q2	asns	Warrants To Purchase Common Stock WarrantsToPurchaseCommonStock	66127	shares
CY2023Q2	asns	Exercise Price Percentage ExercisePricePercentage	1.25	pure
CY2023Q2	us-gaap	General Partners Offering Costs GeneralPartnersOfferingCosts	223000	usd
CY2023Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	172000	usd
CY2023Q4	asns	Prefunded Warrants To Purchase Common Stock PrefundedWarrantsToPurchaseCommonStock	970187	shares
CY2023Q4	asns	Prefunded Warrants PrefundedWarrants	970187	shares
CY2023Q4	asns	Exercise Price Of Prefunded Warrant ExercisePriceOfPrefundedWarrant	0.0001
CY2023	asns	Payments To Underwriter PaymentsToUnderwriter	129000	usd
CY2023Q4	asns	Warrants To Purchase Common Stock WarrantsToPurchaseCommonStock	88983	shares
CY2023	asns	Exercise Price Percentage ExercisePricePercentage	1.25	pure
CY2023	asns	Offering Share Price OfferingSharePrice	1.475
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	230000	usd
CY2022Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	1000000	usd
CY2023	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	7920	shares
CY2023	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	50000	usd
CY2015Q2	us-gaap	Sale Of Stock Percentage Of Ownership Before Transaction SaleOfStockPercentageOfOwnershipBeforeTransaction	0.10	pure
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	96459	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.89
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y4M2D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	400	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.48
CY2023	asns	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Life Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLifeGranted	P9Y8M15D
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2489	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.9
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	6606	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	22.74
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	87764	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.63
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y1M9D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	80064	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.36
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y8M1D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	89049	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.52
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y5M4D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	16778	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	21.96
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	7775	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.81
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1593	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	15.09
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	96459	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.89
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y4M2D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	77196	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.48
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M9D
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	87764	shares
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	80064	shares
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	96459	shares
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	77196	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	17000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	291000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	6000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.2
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.54	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements State And Local EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.09	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.23	pure
CY2023Q4	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	4410000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	121100000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	82000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-4535000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-6368000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-6447000	usd
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-6286000	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-10982000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	28746000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27932000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	28746000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	27932000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	27932000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	31049000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	814000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-3117000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	28746000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	27932000	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.0001
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	87764	shares
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	96459	shares
CY2023	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	3.63
CY2022	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	4.89
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6286000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-10982000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2178178000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1160367000	usd
CY2023	asns	Pre Funded Warrants To Purchase Common Shares PreFundedWarrantsToPurchaseCommonShares	225631	shares
CY2023	asns	Net Loss Attributed Common Shareholders Outstanding Vested Restricted Stock Units NetLossAttributedCommonShareholdersOutstandingVestedRestrictedStockUnits	8908	shares
CY2022	asns	Net Loss Attributed Common Shareholders Outstanding Vested Restricted Stock Units NetLossAttributedCommonShareholdersOutstandingVestedRestrictedStockUnits	1757	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2412717	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1162124	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.61
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-9.45
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2022	asns	Changes In Fair Value Related To Convertible Note ChangesInFairValueRelatedToConvertibleNote	1753000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1658000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1049000	usd
CY2023	us-gaap	Revenues Revenues	5606000	usd
CY2022	us-gaap	Revenues Revenues	8831000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	648000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	673000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	544000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	593000	usd
CY2023	asns	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	356000	usd
CY2022	asns	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	568000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	460000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	648000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	385000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	979000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	806000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.10	pure
CY2022	asns	Changes In Fair Value Related To Convertible Loan ChangesInFairValueRelatedToConvertibleLoan	1648000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	313000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	506000	usd
CY2023	asns	Warrant Issuance Costs WarrantIssuanceCosts	223000	usd
CY2023	asns	Other Financial Income Expenses OtherFinancialIncomeExpenses	95000	usd
CY2022	asns	Other Financial Income Expenses OtherFinancialIncomeExpenses	-107000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1843000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4051000	usd
CY2015Q1	us-gaap	Management Fee Payable ManagementFeePayable	5000	usd
CY2023	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	150000	usd
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	4000000	usd
CY2022Q1	us-gaap	Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount	100000	usd
CY2023	asns	Aggregate Amount aggregateAmount	100000	usd
CY2023	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	150000	usd
CY2017Q1	us-gaap	Convertible Debt ConvertibleDebt	26000	usd
CY2022Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	59200	shares
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2022Q4	us-gaap	Restricted Cash Equivalents Current RestrictedCashEquivalentsCurrent		usd
CY2023Q4	asns	Restricted Bank Deposits Current RestrictedBankDepositsCurrent		usd
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	asns	Warrants To Placement Agent WarrantsToPlacementAgent		usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue		usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023	asns	Stock Issue During Period Value Exercise Of Prefunded Warrants Into Common Stock StockIssueDuringPeriodValueExerciseOfPrefundedWarrantsIntoCommonStock		usd
CY2022	asns	Warrant Issuance Costs WarrantIssuanceCosts		usd
CY2023	asns	Changes In Fair Value Related To Convertible Loan ChangesInFairValueRelatedToConvertibleLoan		usd
CY2023	asns	Changes In Fair Value Related To Convertible Note ChangesInFairValueRelatedToConvertibleNote		usd
CY2022	asns	Long Term Restricted Bank Deposits LongTermRestrictedBankDeposits		usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022Q4	us-gaap	Restricted Cash Equivalents Current RestrictedCashEquivalentsCurrent		usd
CY2023	asns	Conversion Of Convertible Loan To Common Stock Upon Initial Public Offering ConversionOfConvertibleLoanToCommonStockUponInitialPublicOffering		usd
CY2023	asns	Conversion Of Convertible Note To Common Stock Upon Initial Public Offering ConversionOfConvertibleNoteToCommonStockUponInitialPublicOffering		usd
CY2023	asns	Conversion Of Warrant To Common Stock Upon Initial Public Offering ConversionOfWarrantToCommonStockUponInitialPublicOffering		usd
CY2023	asns	Conversion Of Convertible Redeemable Preferred Stock To Common Stock Upon Initial Public Offering ConversionOfConvertibleRedeemablePreferredStockToCommonStockUponInitialPublicOffering		usd
CY2023	asns	Repurchases Of Common Stock RepurchasesOfCommonStock		usd
CY2022	asns	Issuance Costs Of Common Stock Prefunded Warrants And Warrants IssuanceCostsOfCommonStockPrefundedWarrantsAndWarrants		usd
CY2022	asns	Reclassification Of Warrants From Liability To Equity Upon Amendment To Private Placement Agreem ReclassificationOfWarrantsFromLiabilityToEquityUponAmendmentToPrivatePlacementAgreem		usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39688000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6577000	usd
CY2021Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure		usd
CY2022Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure		usd
CY2022Q2	us-gaap	Long Term Debt Term LongTermDebtTerm	P3Y
CY2022Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures		usd
CY2022	us-gaap	Additions To Other Assets Amount AdditionsToOtherAssetsAmount		usd
CY2022	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices		usd
CY2023Q4	asns	Conversion To The Companys Common Stock ConversionToTheCompanysCommonStock		usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1162124	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2412717	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.61
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-9.45
CY2023	asns	Changes In Fair Value Related To Convertible Loan ChangesInFairValueRelatedToConvertibleLoan		usd
CY2023	asns	Changes In Fair Value Related To Convertible Note ChangesInFairValueRelatedToConvertibleNote		usd
CY2022	asns	Warrant Issuance Costs WarrantIssuanceCosts		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001141284

Files In Submission

Name	View Source	Status
0001213900-24-026069-index-headers.html	Edgar Link	pending
0001213900-24-026069-index.html	Edgar Link	pending
0001213900-24-026069.txt	Edgar Link	pending
0001213900-24-026069-xbrl.zip	Edgar Link	pending
asns-20231231.xsd	Edgar Link	pending
ea0202031-10k_actelis.htm	Edgar Link	pending
ea020203101ex23-1_actelis.htm	Edgar Link	pending
ea020203101ex31-1_actelis.htm	Edgar Link	pending
ea020203101ex31-2_actelis.htm	Edgar Link	pending
ea020203101ex32-1_actelis.htm	Edgar Link	pending
ea020203101ex32-2_actelis.htm	Edgar Link	pending
ea020203101ex97-1_actelis.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fin_001.jpg	Edgar Link	pending
fin_002.jpg	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
asns-20231231_cal.xml	Edgar Link	unprocessable
asns-20231231_lab.xml	Edgar Link	unprocessable
asns-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0202031-10k_actelis_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
asns-20231231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ASNS
ACTELIS NETWORKS INC Stock $asns

2024 Q1 Form 10-K Financial Statement

#000121390024026069 Filed on March 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ASNS ACTELIS NETWORKS INC Stock $asns

2024 Q1 Form 10-K Financial Statement

#000121390024026069 Filed on March 26, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ASNS
ACTELIS NETWORKS INC Stock $asns